In this position statement, developed by The International College of Obsessive-Compulsive
Spectrum Disorders, a group of international experts responds to recent developments in the …

The obsessive–compulsive spectrum refers to disorders drawn from several diagnostic
categories that share core features related to obsessive–compulsive disorder (OCD), such …

Serotonin reuptake inhibitor (SRI) medications are well established as first-line
pharmacotherapeutic treatment for Obsessive-Compulsive Disorder (OCD). However …

Methods This systematic review aims to investigate the effects of ketamine in OCD, following
the Preferred Reporting Items for Systematic Review and Meta-analyses Protocols (PRISMA …

Background Limited published data exists that collates serious adverse outcomes involving
ketamine as a psychiatric intervention. This systematic review assesses the reported …

Glutamate modulators are used to treat OCD resistant to serotonin reuptake inhibitors
(SRIs). Ketamine has shown some promise in treating OCD. Data on the use of ketamine in …

Background The concepts of superstitions, routines, and peculiar behaviors in sports have
been well characterized and sometimes associated with “obsessions” and “compulsions.” …

O bsessive-compulsive disorder (OCD) is a disabling illness affecting approximately 2%-3%
individuals worldwide that is marked by recurrent, distressing intrusive thoughts …

Objectives: To summarize evidence-based pharmacological treatments and provide
guidance on clinical interventions for adult patients with obsessive-compulsive disorder …

Introduction Over the past decade, glutamate has emerged as a prominent focus in the field
of obsessive-compulsive disorder (OCD) pathophysiology. A convergence of evidence from …